Anavex Life Sciences Corp. Forecast and Stock Analysis
Technical AVXL stock analysis for Friday June 14, 2019.
Anavex Life Sciences Corp. fell by -6.99% in the last day ( Friday, 14th Jun 2019 ) from $3.29 to $3.06 During day the stock fluctuated 12.08% from a day low at $2.98 to a day high of $3.34. The price has risen in 6 of the last 10 days and is up by 5.88% over the past 2 weeks. Volume has increased in the last day by 147 944 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 439 299 shares bought and sold for approximately $1.34 million.
- 30 day high of the AVXL stock price was $3.95 and low was $2.84.
- 90 day high was $4.00 and low was $2.70.
- 52 week high for the Anavex Life Sciences Corp. - $4.35 and low - $1.25.
Anavex Life Sciences Corp. lies in the lower part of a very wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $2.90 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.61% during the next 3 months and, with 90% probability hold a price between $3.06 and $3.96 at the end of this period.
There are few to none technical positive signals at the moment. Anavex Life Sciences Corp. holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $3.11 and $3.17. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday June 13, 2019, which indicates further falls until a new bottom pivot has been found. Anavex Life Sciences Corp. gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSI14 is 40 and the stock is currently not being overbought or oversold
Support & Resistance
Anavex Life Sciences Corp. finds support from accumulated volume at $2.95.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.36 between high and low, or 12.08%. For the last week, the stock has had a daily average volatility of 6.89%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
6.89 %Average volatility
Very Low Low Medium High Very High
The Anavex Life Sciences Corp. stock holds several negative signals and despite the positive trend we believe Anavex Life Sciences Corp. will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Sell Candidate.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|AVXL $3.06 ($-0.23 -6.99%)|
AVXL is down $0.23 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AVXL based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AVXL analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us